Dejan Milentijevic

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Direct Oral Anticoagulants

Top Venues

American journal of hematology

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Dejan Milentijevic, Jennifer H Lin, Yen-Wen Chen, Emily Kogan, Shubham Shrivastava, Erik Sjoeland, Mark J Alberts
Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin. Journal of medical economics 24 (1) (2021)
Alok A Khorana, Keith McCrae, Dejan Milentijevic, Nora McCormick, François Laliberté, Concetta Crivera, Patrick Lefebvre, Dominique Lejeune, Heather Rozjabek, Jeff Schein, Michael B Streiff
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation. American journal of hematology 94 (2) (2018)
Michael B Streiff, Dejan Milentijevic, Keith McCrae, Daniel Yannicelli, Jonathan Fortier, Winnie W Nelson, François Laliberté, Concetta Crivera, Patrick Lefebvre, Jeff Schein, Alok A Khorana
Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer. American journal of hematology 93 (5) (2018)
Michael B Streiff, Dejan Milentijevic, Keith McCrae, Daniel Yannicelli, Dominique Lejeune, Winnie W Nelson, François Laliberté, Concetta Crivera, Patrick Lefebvre, Jeff Schein, Alok A Khorana
An answer to "anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution". American journal of hematology 93 (9) (2018)